LMAT (LMAT) CEO LeMaitre reports 205,930-share sale, PSU vesting and gift

Rhea-AI Filing Summary

LEMAITRE VASCULAR INC Chairman and CEO George W. LeMaitre reported a mix of stock sales, awards, and transfers. He sold an aggregate 205,930 shares of common stock in open-market transactions on February 26, 2026 and March 2, 2026, at weighted average prices of $106.7557 and $107.8137 per share, including sales made under a Rule 10b5-1(c) trading plan adopted on March 10, 2025.

On February 26, 2026, he received 5,609 shares upon settlement of a performance share unit award, plus 13 shares from related dividend equivalent rights, and 13 additional common shares from a derivative conversion. The company withheld 496 shares to cover tax obligations on the vesting PSUs.

On March 2, 2026, he made a bona fide gift transfer of 5,000 common shares. Separately, 33,400 shares are held by an irrevocable trust for the benefit of his children, for which he disclaims beneficial ownership except to the extent of any pecuniary interest.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

LeMaitre George W

(Last) (First) (Middle)

C/O LEMAITRE VASCULAR, INC.

63 SECOND AVENUE

(Street)

BURLINGTON MA 01803

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
LEMAITRE VASCULAR INC [ LMAT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chairman and CEO

3. Date of Earliest Transaction (Month/Day/Year)
02/26/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/26/2026		S		150,000	D	$106.7557(1)(2)	1,532,304	D
Common Stock	02/26/2026		A		5,609(3)	A	$0	1,537,913	D
Common Stock	02/26/2026		M		13(4)	A	$0(4)	1,537,926	D
Common Stock	02/26/2026		F		496(5)	D	$113.69	1,537,430	D
Common Stock	03/02/2026		G		5,000	D	$0	1,532,430	D
Common Stock	03/02/2026		S		55,930	D	$107.8137(6)	1,476,500	D
Common Stock								33,400	I	LEMAITRE IRREVOCABLE LIFE INSURANCE TRUST OF 2025(7)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Dividend Equivalent Rights	(8)	02/26/2026		M			13(8)	(8)	(8)	Common Stock	13	$0	32.87	D

Explanation of Responses:

1. Sold pursuant to a 10b5-1(c) plan adopted 03-10-2025.

2. The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $103.05 to $113.50. The reporting person undertakes to provide to the issuer, any securityholder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected.

3. These shares represent LMAT common stock acquired on February 26, 2026, upon settlement of a Performance Share Unit (PSU) award granted on December 6, 2024. The PSU award vested 25% upon determination of satisfaction of the performance condition (on 2/26/2026), and the balance vests in equal annual installments on the grant date anniversary over the next three years.

4. Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis.

5. These shares represent shares withheld by the Issuer to satisfy tax withholding obligations incurred upon the vesting of PSUs awarded to the reporting person on December 6, 2024. This transaction is considered an exempt sale pursuant to Rule 16b-3(e) promulgated under the Securities Exchange Act of 1934.

6. The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $106.95 to $109.49. The reporting person undertakes to provide to the issuer, any securityholder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected.

7. These shares are held by an irrevocable trust for the benefit of Reporting Person's child(ren). The Reporting Person disclaims ownership of such securities except to the extent of his pecuniary interest therein, if any, and the reporting herein of such securities shall not be construed as an admission of beneficial ownership thereof for the purposes of Section 16 or for any other purpose.

8. These dividend equivalent rights were released in connection with the vesting of a PSU award granted on December 6, 2024. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

	/s/ Laurie A. Churchill, Attorney-in-fact	03/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transactions did LMAT CEO George LeMaitre report?

George LeMaitre reported open-market sales, equity awards, and a gift. He sold 205,930 LMAT common shares in late February and early March 2026, received shares from a performance share unit vesting, had shares withheld for taxes, and made a 5,000-share bona fide gift.

How many LMAT shares did the CEO sell and at what prices?

He sold 205,930 LMAT common shares across two transactions. Weighted average sale prices were $106.7557 per share on February 26, 2026, and $107.8137 per share on March 2, 2026, executed as open-market or private transactions according to the Form 4 details.

Was any part of the LMAT CEO’s stock sale under a 10b5-1 plan?

Yes. Some LMAT share sales were executed under a Rule 10b5-1(c) trading plan adopted on March 10, 2025. Such plans allow pre-arranged trading, helping insiders trade shares over time without making discretionary timing decisions later.

What equity awards did the LMAT CEO receive on February 26, 2026?

He acquired 5,609 LMAT common shares from settlement of a performance share unit (PSU) award granted December 6, 2024. The PSU vested 25% upon performance determination on February 26, 2026, with the remaining portions vesting in equal annual installments over the next three years.

Why were some LMAT shares withheld from the CEO’s holdings?

The company withheld 496 LMAT common shares to satisfy tax withholding obligations triggered by the vesting of the CEO’s PSU award dated December 6, 2024. This tax-withholding disposition is treated as an exempt transaction under Rule 16b-3(e) of the Exchange Act.

How are the LMAT shares held in the irrevocable trust reported?

The Form 4 shows 33,400 LMAT shares held by an irrevocable trust for the benefit of the CEO’s children. He disclaims beneficial ownership of these shares except for any pecuniary interest, and their reporting does not constitute an admission of beneficial ownership under Section 16.